Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I-II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group study.
Miller WH Jr, Reyno LM, Loewen GR, Huan S, Winquist E, Moore M, Cato A 3rd, Jaunakais D, Truglia JA, Matthews S, Dancey J, Eisenhauer E. Miller WH Jr, et al. Among authors: loewen gr. Ann Oncol. 2000 Nov;11(11):1387-9. doi: 10.1023/a:1026579400806. Ann Oncol. 2000. PMID: 11142476 Free article. Clinical Trial.
A Phase I study of LGD1069 in adults with advanced cancer.
Rizvi NA, Marshall JL, Dahut W, Ness E, Truglia JA, Loewen G, Gill GM, Ulm EH, Geiser R, Jaunakais D, Hawkins MJ. Rizvi NA, et al. Among authors: loewen g. Clin Cancer Res. 1999 Jul;5(7):1658-64. Clin Cancer Res. 1999. PMID: 10430065 Clinical Trial.
Initial clinical trial of a selective retinoid X receptor ligand, LGD1069.
Miller VA, Benedetti FM, Rigas JR, Verret AL, Pfister DG, Straus D, Kris MG, Crisp M, Heyman R, Loewen GR, Truglia JA, Warrell RP Jr. Miller VA, et al. Among authors: loewen gr. J Clin Oncol. 1997 Feb;15(2):790-5. doi: 10.1200/JCO.1997.15.2.790. J Clin Oncol. 1997. PMID: 9053506 Clinical Trial.
Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.
Duvic M, Friedman-Kien AE, Looney DJ, Miles SA, Myskowski PL, Scadden DT, Von Roenn J, Galpin JE, Groopman J, Loewen G, Stevens V, Truglia JA, Yocum RC. Duvic M, et al. Among authors: loewen g. Arch Dermatol. 2000 Dec;136(12):1461-9. doi: 10.1001/archderm.136.12.1461. Arch Dermatol. 2000. PMID: 11115156 Clinical Trial.
Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain.
Portenoy RK, Sciberras A, Eliot L, Loewen G, Butler J, Devane J. Portenoy RK, et al. Among authors: loewen g. J Pain Symptom Manage. 2002 Apr;23(4):292-300. doi: 10.1016/s0885-3924(02)00382-2. J Pain Symptom Manage. 2002. PMID: 11997198 Free article. Clinical Trial.
84 results